Patents by Inventor Van-Yu Wu

Van-Yu Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND COMPOSITIONS COMPRISING 2-[(3-CHLOROPHENYL) AMINO] PHENYLACETIC ACID FOR HYPERPERMEABILITY AND NEOVASCULARIZATION DISORDERS OF THE RETINA
    Publication number: 20100035993
    Abstract: Method of preventing or arresting the progression of hyperpermeability and neovascularization of the retina by administering to a patient at risk for retinal microvascular disease a composition comprising a compound or pharmaceutically acceptable salt thereof that lowers the ocular ratio of VEGF to PEDF.
    Type: Application
    Filed: August 6, 2008
    Publication date: February 11, 2010
    Inventors: Margo P. Cohen, Clyde W. Shearman, Van-Yu Wu
  • Method for measurement of glycated hemoglobin by a rapid strip test procedure
    Patent number: 6677158
    Abstract: The present invention is directed to a novel method for measurement of glycated hemoglobin, as well as assay methods and processes that can be used outside the medical laboratory setting to determine the fraction of total hemoglobin that is glycated.
    Type: Grant
    Filed: March 14, 2001
    Date of Patent: January 13, 2004
    Assignee: Exocell Inc.
    Inventors: Elizabeth A. Hud, Clyde W. Shearman, Van-Yu Wu
  • Novel method for measurement of glycated hemoglobin by a rapid strip test procedure
    Publication number: 20020164811
    Abstract: The present invention is directed to a novel method for measurement of glycated hemoglobin, as well as assay methods and processes that can be used outside the medical laboratory setting to determine the fraction of total hemoglobin that is glycated.
    Type: Application
    Filed: March 14, 2001
    Publication date: November 7, 2002
    Inventors: Elizabeth A. Hud, Clyde W. Shearman, Van-Yu Wu
  • Isolation of a soluble 42 KD pancreatic islet cell autoantigen
    Patent number: 5312628
    Abstract: A method of isolating soluble pancreatic islet antigen employs extraction with a non-ionic detergent and fractionation on a gel filtration column. Fractions are screened for high immunoreactivity with diabetic serum which is positive for ICA immunofluorescence when tested on tissue sections of a pancreas from a human blood group O donor. The isolated soluble antigen is suitable for measuring autoantibodies in both complement fixation assays as well as ELISA-type and immunoblotting formats. Methods of using isolated soluble antigen to test serum for autoantibodies are also taught.
    Type: Grant
    Filed: May 12, 1993
    Date of Patent: May 17, 1994
    Assignee: Exocell, Inc.
    Inventors: Margo P. Cohen, Van-Yu Wu